Implications of the EMA-FDA Parallel Scientific Advice for China Communication System

Implications of the EMA-FDA Parallel Scientific Advice for China Communication System

ZHANG Siyao, LIANG Yi

PDF(2021 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(2021 KB)

Chinese Journal of Pharmaceuticals ›› 2023, Vol. 54 ›› Issue (08) : 1259-1264. DOI: 10.16522/j.cnki.cjph.2023.08.017

Pharmaceutical Management & Information

Implications of the EMA-FDA Parallel Scientific Advice for China Communication System

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 54(08): 1259-1264 https://doi.org/10.16522/j.cnki.cjph.2023.08.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(2021 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉